Showing 1 - 20 results of 61 for search '"Mycosis"', query time: 0.05s Refine Results
  1. 1
  2. 2
  3. 3

    Mycosis Fungoides Involving the Dorsal Tongue by Ashley E. Brown, Lindsey Schmidtberger, Kathleeen Kroger, Richard R. Jahan-Tigh, Sarah S. Pinney

    Published 2018-01-01
    “…Mycosis fungoides (MF) is a rare cutaneous T-cell lymphoma (CTCL) which can cause significant morbidity. ​…”
    Get full text
    Article
  4. 4

    Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides by Alfonso Dueñas-Gonzalez, Maria Teresa Vega, Déborah Martinez-Baños, Linda García-Hidalgo, Pedro Sobrevilla

    Published 2010-01-01
    “…The epigenetic alterations of CTCL not only are limited to altered histone acetylation but also include aberrant DNA gene methylation hence, the combination of an HDAC inhibitor with a DNA demethylating agent is a promising therapy to be tested. Here we report a mycosis fungoides patient having a dramatic response to hydralazine and valproate, two repositioned drugs as HDAC and DNA methylation inhibitors, respectively.…”
    Get full text
    Article
  5. 5

    Childhood Hypopigmented Mycosis Fungoides: A Rare Diagnosis by Cláudia Patraquim, Maria Miguel Gomes, Carla Garcez, Filipa Leite, Tereza Oliva, António Santos, Armando Pinto

    Published 2016-01-01
    “…Primary cutaneous lymphomas (PCL) are rare in pediatrics. Mycosis fungoides (MF) is the most frequent PCL diagnosed in childhood. …”
    Get full text
    Article
  6. 6

    Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources by Mona Abdel-Halim Ibrahim, Nada Eltayeb, Mirna Michel Ibrahim, Ahmed Nassar, Maged Daruish, Maha El-Zimaity, Mahmoud El-Lithy, Ahmed Mostafa, Amal El-Afifi, Haitham Abdelbary, Mahira Hamdy El-Sayed

    Published 2023-01-01
    “…The treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. …”
    Get full text
    Article
  7. 7

    Hypopigmented Mycosis Fungoides in an 11-Year-Old Palestinian Boy by Duha Rabi, Balqis Shawer, Ahmad Rabee, Mohammad Qudaimat, Mohammad Milhem, Izzeddin Bakri

    Published 2023-01-01
    “…The most common subtype of CTCL in pediatrics is mycosis fungoides (MF). There are multiple variants of MF. …”
    Get full text
    Article
  8. 8

    A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides by Ethan A. Burns, Cesar Gentille, Saro Kasparian, Sai Ravi Pingali

    Published 2019-01-01
    “…To our knowledge, this is the first reported case of HS occurring as a second primary malignancy in a patient with mycosis fungoides (MF), with the retained immunophenotype markers CD30 and CD4.…”
    Get full text
    Article
  9. 9
  10. 10

    PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides by Birgül Özkesici, Saliha Koç, Ayşe Akman-Karakaş, Ertan Yılmaz, İbrahim Cumhur Başsorgun, Soner Uzun

    Published 2017-01-01
    “…Herein, we report a case of BP that occurred in a patient who was receiving PUVA therapy for the treatment of mycosis fungoides. Main Observation. A 26-year-old woman with mycosis fungoides developed blisters while receiving PUVA therapy. …”
    Get full text
    Article
  11. 11

    Interstitial Mycosis Fungoides: An Unusual Mimic of Interstitial Granuloma Annulare Not to Miss by Neha Singh, Kiley K. Fagan, Douglas J. Grider

    Published 2022-01-01
    “…Interstitial mycosis fungoides is a rare histopathologic variant of mycosis fungoides that may resemble interstitial granuloma annulare, inflammatory morphea, and interstitial granulomatous dermatitis. …”
    Get full text
    Article
  12. 12
  13. 13
  14. 14

    Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides by Serkan Yazıcı, Emel Bülbül Başkan, Ferah Budak, Barbaros Oral, Şaduman Balaban Adim, Zübeyde Ceylan Kalin, Güven Özkaya, Kenan Aydoğan, Hayriye Saricaoğlu, Şükran Tunali

    Published 2015-01-01
    “…We retrospectively analyzed the clinicopathological correlation and prognostic value of cell surface antigens expressed by peripheral blood mononuclear cells in patients with mycosis fungoides (MF). 121 consecutive MF patients were included in this study. …”
    Get full text
    Article
  15. 15

    Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases by Ranthilaka R. Ranawaka, Priyanka H. Abeygunasekara, M. V. Chandu de Silva

    Published 2011-01-01
    “…Five patients with type V skin were studied to describe the clinical manifestations, pathological features, and treatment response in hypopigmented mycosis fungoides (HMF). The mean age of patients was 22.4 years at diagnosis, with a mean of 36 months of diagnostic delay. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18

    Photodynamic Therapy with the Silicon Phthalocyanine Pc 4 Induces Apoptosis in Mycosis Fungoides and Sezary Syndrome by Minh Lam, YooJin Lee, Min Deng, Andrew H. Hsia, Kelly A. Morrissey, Chunlin Yan, Kashif Azzizudin, Nancy L. Oleinick, Thomas S. McCormick, Kevin D. Cooper, Elma D. Baron

    Published 2010-01-01
    “…Our current focus on the effects of Photodynamic Therapy (PDT) using silicon phthalocyanine Pc 4 photosensitizer on malignant T lymphocytes arose due to preclinical observations that Jurkat cells, common surrogate for human T cell lymphoma, were more sensitive to Pc 4-PDT-induced killing than epidermoid carcinoma A431 cells. Mycosis fungoides (MF) as well as Sezary syndrome (SS) are variants of cutaneous T-cell lymphoma (CTCL) in which malignant T-cells invade the epidermis. …”
    Get full text
    Article
  19. 19
  20. 20